← All stocks

Phathom Pharmaceuticals, Inc.

PHAT Net selling
CIK 0001783183 #2855 in the set updated 19 Sep 2026
Bought (120 mo)
$45.78M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$113.32M
$74.53K on a plan · $21.35M straight out of an exercise
Sold at will
$91.90M
158 of 166 sales
Net
−$67.54M
−$46.12M against sales at will

By person

20 insiders · 203 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
TAKEDA PHARMACEUTICAL CO LTD entity
10% owner
$58.48M (51)
−$58.48M
3,755,583
$50.74M
+246.5%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$4.41M (3)
$31.06M (1)
−$26.65M
3,115,008
$42.08M
−14.6%
Edwards Jonathan S.
Director
$20.00M (2)
+$20.00M
2,067,861
$27.94M
Frazier Life Sciences IX, L.P.
10% owner
$20.00M (1)
+$20.00M
5,842,352
$78.93M
+19.4%
Socks David A
Director
$17.88M (57)
−$17.88M
2,478,399
$33.48M
−14.8%
Nabulsi Azmi
Chief Operating Officer
$245.89K (2)
$4.18M (32)
−$3.94M
2,113,937
$28.56M
+11.7%
Curran Terrie
President and Chief Executive
$252.86K (2)
$1.25M (8)
−$996.63K
360,465
$4.87M
+3,546%
Henderson Molly
CFO and CBO
(1)
$447.02K (14)
−$447.02K
192,631
$2.60M
+393.1%
Parikh Asit
Director
$390.22K (11)
+$390.22K
172,622
$2.33M
Topper James N
Director
$191.99K (6)
+$191.99K
126,121
$1.70M
+901.3%
COLA MICHAEL F
Director
$186.16K (1)
+$186.16K
63,920
$863.56K
KARBE FRANK
Director
$99.08K (1)
+$99.08K
91,622
$1.24M
Breedlove Robert Charles
Principal Accounting Officer
$26.80K (3)
−$26.80K
67,657
$914.04K
+14.8%
Basta Steven L
President and CEO
373,315
$5.04M
+15,390%
Narula Sanjeev
Chief Financial & Bus. Officer
226,715
$3.06M
+57.4%
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
88,660
$1.20M
+5,049%
FIELDS HEIDI
Director
54,122
$731.19K
Stenhouse Mark
Director
54,122
$731.19K
Schroeder Theodore R
Director
45,122
$609.60K
Guzzo Anthony J.
VP, Chief Accounting Officer
8,399
$113.47K
+250.1%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Parikh Asit
20 May 2026
Director
Exercised, kept
17,500
$4.95
$86.63K
Parikh Asit
13 Jan 2026
Director
Exercised, kept
8,750
$10.30
$90.13K
Parikh Asit
19 Dec 2025
Director
Exercised, kept
8,750
$10.30
$90.13K
Parikh Asit
10 Sep 2024
Director
Exercised, kept
7,500
$11.72
$87.90K
Frazier Life Sciences IX, L.P.
29 Oct 2019
10% owner
Exercised, kept
1,353,640
$15.20
$20.58M
Edwards Jonathan S.
29 Oct 2019
Director
Exercised, kept indirect
23,558
$15.20
$358.08K
Edwards Jonathan S.
29 Oct 2019
Director
Exercised, kept indirect
991,672
$15.20
$15.07M

What was left out

Form 4 filings counted 194
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 5
Sales at will 158
Transactions with no price 1
Shares from compensation/vesting 15,691,222
Sales filed before the plan box existed 139
History held since 30 Oct 2019